Novavax misses quarterly estimates, but vaccine maker narrows losses as it slashes costsCNBC • 02/28/24
Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsPRNewsWire • 02/28/24
Novavax (NVAX) Surges 8.4%: Is This an Indication of Further Gains?Zacks Investment Research • 02/26/24
Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase AgreementPRNewsWire • 02/22/24
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024PRNewsWire • 02/20/24
3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street AnalystsThe Motley Fool • 01/31/24
Is Novavax Stock A Buy After Winning A Key Designation From The World Health Organization?Investors Business Daily • 01/25/24
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?The Motley Fool • 01/23/24